MedPath

Providing Personalized Health and Individual Lifestyle Enhancing Solutions (Prophiles) in CVD

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Interventions
Behavioral: Lifestyle Management
Behavioral: Control Group
Registration Number
NCT03643146
Lead Sponsor
NYU Langone Health
Brief Summary

The objective of the proposed project is to evaluate the usability, acceptability, and adherence of a lifestyle and behavioral self-tracking and ePersuasive tool aimed at improving: 1) adherence to diet/nutrition (\<1500 mg of sodium/day and less than 10% daily free sugar intake), physical activity (PA) (150 minutes of moderate PA/week), and sleep guidelines (7-8 hours of sleep/day)-- and 2) control 3% reduction in systolic BP and glucose from baseline to end of study follow-up after 2 months (exploratory objective) in a sample of 20 patients with Hypertension or Diabetes. The study will utilize a Step-Wedge Design where the 20 patients will be divided into 4 wedges (5 patients in each wedge).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • NYU and/or Bellevue patient
  • Diagnosed with HTN and pre-diabetes/diabetes
  • Must be English speakers
  • Ownership of a smart phone and are willing to use it to download app built in TrialX which will be free for participants
  • Must be ambulatory
Read More
Exclusion Criteria
  • are unable or unwilling to provide informed consent;
  • are unable to participate meaningfully in an intervention that involves self-monitoring using software available in English (e.g., due to uncorrected sight impairment, illiterate, non-English-speaking, dementia);
  • are pregnant, are currently trying to become pregnant, or who become pregnant during the study
  • are institutionalized (e.g., in a nursing home or personal care facility, or those who are incarcerated and have limited control over self-management)
  • have had or are planning to have bariatric surgery during the study
  • have a history of heart disease, kidney disease, or retinopathy (to rule-out those with long-standing, undiagnosed T2D)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Wedge 1-Step 4Lifestyle Management-
Wedge 3- Step 3Control Group-
Wedge 3- Step 4Lifestyle Management-
Wedge 1- Step 1Control Group-
Wedge 1-Step 5Lifestyle Management-
Wedge 2- Step 1Control Group-
Wedge 2-Step 2Control Group-
Wedge 2-Step 3Lifestyle Management-
Wedge 3- Step 2Control Group-
Wedge 1-Step 2Lifestyle Management-
Wedge 1-Step 3Lifestyle Management-
Wedge 2-Step 4Lifestyle Management-
Wedge 3-Step 1Control Group-
Wedge 3- Step 5Lifestyle Management-
Wedge 4-Step 3Control Group-
Wedge 2-Step 5Lifestyle Management-
Wedge 4-Step 1Control Group-
Wedge 4- Step 2Control Group-
Wedge 4-Step 4Lifestyle Management-
Wedge 4-Step 5Lifestyle Management-
Primary Outcome Measures
NameTimeMethod
Measure of physical activity by the International Physical Activity Questionnaire (IPAQ)12 Months

Used to assess physical activity and calculate metabolic equivalent

User Acceptance measured by adherence to diet and nutrition using the Healthy Eating Survey12 Months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath